wound cleansing 2.0
women ' s daughters 2.0
weeks ' anticoagulation therapy 2.0
verbal analogue pain scores 2.0
united nations population fund 2.0
twin pregnancy 2.0
true treatment effect differences 2.0
treatment regimes 2.0
treatment components 2.0
training effect 2.0
tpn patients 2.0
topical mast cell stabilisers 2.0
third trimester 2.0
thermic gradient 2.0
therapeutic efficacy 2.0
test ' s outcome 2.0
temporary right atrial pacing 2.0
tb cases 2.0
t-cell percentage 2.0
system ' s database 2.0
suspected acute myocardial infarction 2.0
successful treatment completion rates 2.0
study purpose 2.0
special demands 2.0
south india 2.0
smoking cessation incentive program 2.0
small gastric carcinoid tumours 2.0
single course 2.0
simultaneous use 2.0
simple short-term dietary measures 2.0
severe right ventricular dysfunction 2.0
severe group 2.0
severe chronic airflow limitation 2.0
seventy-one patients 2.0
seventy-one female rape victims 2.0
serum aspartate aminotransferase level 2.0
serotonin uptake inhibitor fluvoxamine 2.0
selective serotonin uptake inhibitor 2.0
secondary prophylaxis 2.0
second generation antipsychotic olanzapine 2.0
seasonal influenza 2.0
same regimen 2.0
sagittal mobility 2.0
routine blood chemistry measurements 2.0
review data 2.0
retinoic acid response element 2.0
respiratory depression 2.0
rehabilitation programmes 2.0
regular palpable uterine contractions 2.0
reducing allogeneic blood requirements 2.0
recombinant follicle stimulating hormone 2.0
randomized prospective control study 2.0
randomized placebo-controlled parallel study 2.0
randomized patients 2.0
pulse rate 2.0
pulmonary metastases 2.0
published literature 2.0
psychotherapy patients 2.0
psychological benefit 2.0
proximal femoral venous thrombosis 2.0
protective anti-hbs antibody titer 2.0
prospective controlled clinical trial 2.0
prolonged use 2.0
primary tumor 2.0
previous study 2.0
presenting clinical trial information 2.0
preoperative reservation 2.0
postoperative total knee arthroplasties 2.0
postoperative antibiotics 2.0
population tobacco control interventions 2.0
plasma volume 2.0
permanent dentition 2.0
peripheral circulation 2.0
palliative care 2.0
own dvt prophylaxis protocol 2.0
overall postoperative morbidity rate 2.0
overall postoperative complication rate 2.0
outpatient alcohol rehabilitation programme 2.0
oral surgery 2.0
opioid sparing 2.0
older control patients group 2.0
nova t 2.0
northern ghana 2.0
normal volunteers 2.0
norm setting 2.0
non-specific skin conductance responses 2.0
new york city hospitals 2.0
new methods 2.0
national institute 2.0
music conditions 2.0
multiple logistic regression analyses 2.0
mortality rates 2.0
month trial 2.0
mm visual analogue scale 2.0
metabolic control 2.0
membrane size 2.0
meeting research diagnostic criteria 2.0
medication scores 2.0
medication ' s effects 2.0
mean postoperative blood replacement 2.0
many relevant treatment outcomes 2.0
many individuals 2.0
many health care markets 2.0
male counterparts 2.0
major gastrointestinal elective surgery 2.0
lower respiratory tract infection 2.0
lower patient fall rate 2.0
lower mean 2.0
lower dysfunctional parenting styles 2.0
low dose intravenous heparin 2.0
local metal debris release 2.0
local control 2.0
local anaesthetics 2.0
ligament reconstruction 2.0
lifetime structural valve failure 2.0
life index 2.0
least mild tardive dyskinesia 2.0
language abilities 2.0
laboratory safety 2.0
kg normal saline solution 2.0
key words 2.0
internal locus 2.0
internal experiences 2.0
intention-to-treat analysis 2.0
intensive interventions 2.0
intensive glucose 2.0
intensive care unit patients 2.0
intellectual disability 2.0
inpatient beds 2.0
initial obliteration 2.0
inhalation group 2.0
infusion therapy 2.0
impulse system foot pump 2.0
improving mental health practice 2.0
improved care 2.0
impacted third molar teeth 2.0
hypertrophic scars 2.0
hydrochlorothiazide group 2.0
hyaluronic acid 2.0
human umbilical vein grafts 2.0
human recombinant factor viia 2.0
human factors development approach 2.0
housing interventions 2.0
hour intervals 2.0
hiv-infected injection drug users 2.0
hiv disease 2.0
high-risk subjects 2.0
high serum gastrin concentrations 2.0
high glucose delivery rates 2.0
high birth weight babies 2.0
height velocities 2.0
hamilton depression 2.0
group differences 2.0
gram-negative bacteremias 2.0
gp use 2.0
general practitioners ' roles 2.0
gastrointestinal tumor study group 2.0
future intervention research design 2.0
future directions 2.0
fs screening 2.0
follow-up visits 2.0
foetal outcomes 2.0
fecal occult blood testing 2.0
extensive search 2.0
experimental infants 2.0
essential medications 2.0
equivalent protective immune responses 2.0
equal groups 2.0
epidermal growth factor receptor 2.0
endotracheal tube 2.0
electronic health 2.0
effectiveness trials 2.0
effective acetylsalicylic acid dosage 2.0
early treatment 2.0
early renal replacement therapy 2.0
early intravenous indomethacin therapy 2.0
early intravenous indomethacin administration 2.0
earlier new bone formation 2.0
e-mail discussions 2.0
durable helper t-cell responses 2.0
drug abuse treatment modality 2.0
double-blind experiment 2.0
dopamine systemic blood pressure 2.0
dilated group 2.0
digit symbol substitution test 2.0
different health care settings 2.0
diaries recording walking ability 2.0
depression scale 2.0
delusional depression 2.0
data sources 2.0
data entry 2.0
daily basis 2.0
curriculum exposure 2.0
cryptococcal meningitis 2.0
cox proportional hazards model 2.0
coronary artery bypass grafts 2.0
consolidation therapy 2.0
consent b 2.0
comprehensive evaluation 2.0
component model 2.0
college students ' responsiveness 2.0
collagenase ointment 2.0
cognitive therapy 2.0
cognitive tests 2.0
clinical tests 2.0
clinical presentation 2.0
clinical evidence 2.0
clinical care 2.0
chronic schizophrenia 2.0
children ' s toothpaste 2.0
changes physicians ' prescribing 2.0
cervical canal 2.0
cell salvage auto transfusion 2.0
caudal analgesia 2.0
cancer risk 2.0
brief interventions 2.0
brief alcohol preventive intervention 2.0
bloody diarrhoea 2.0
bishop score 2.0
birth order 2.0
biological parameters 2.0
better scores 2.0
better airway secretion score 2.0
benign disease 2.0
bedroom floor 2.0
baseline survey 2.0
baseline serum selenium levels 2.0
ayrshire teenagers ' attitudes 2.0
average sensitivity 2.0
aural canal 2.0
asymptomatic vte 2.0
asthma control 2.0
assisted ventilation 2.0
apo b 2.0
antipsychotic treatment 2.0
antihypertensive agent 2.0
advanced non-small-cell lung cancer 2.0
advanced inoperable hepatocellular carcinoma 2.0
adult sexual abuse survivors 2.0
acute major depressive episodes 2.0
acute extensive abdominal operations 2.0
acute exacerbations 2.0
actual duration 2.0
ability score 2.0
clinical benefit 1.67
younger age group 1.58
young pregnant women 1.58
years ' results 1.58
year recurrence rates 1.58
year patency rate 1.58
year old children 1.58
wound drainage volume 1.58
worksite screening programs 1.58
wild-type cc genotype 1.58
well-established health service 1.58
week posttreatment follow-up 1.58
week postoperative questionnaire 1.58
week postnatal questionnaire 1.58
week post-treatment baseline 1.58
week placebo-controlled study 1.58
volunteer community households 1.58
voluntary alcohol intake 1.58
voluntary active euthanasia 1.58
vitamin d treatment 1.58
vitamin c preparation 1.58
visit compliance rate 1.58
veterans affairs studies 1.58
venous thromboembolism prophylaxis 1.58
venous thromboembolic events 1.58
venous occlusion plethysmography 1.58
vancomycin prescribing intervention 1.58
vaginal ring releasing 1.58
useful predictive marker 1.58
useful clinical symptoms 1.58
use latex products 1.58
urine toxicology screens 1.58
uric acid levels 1.58
urban outpatient clinic 1.58
upper extremity exercises 1.58
untested management procedure 1.58
unrelated ami patients 1.58
united nations development 1.58
unipolar affective disorders 1.58
uninfected control group 1.58
undesirable side effects 1.58
uncontrollable variceal hemorrhage 1.58
unclear study quality 1.58
u.s. clinical trial 1.58
u sodium heparin 1.58
tyrosine kinase inhibitors 1.58
two-week monitoring period 1.58
tumor regression grade 1.58
tumor cell killing 1.58
true field settings 1.58
tricuspid valve endocarditis 1.58
treatment development research 1.58
treating nonresponder patients 1.58
traditional risk factors 1.58
traditional cold knife 1.58
traditional breathing circuit 1.58
total time patients 1.58
total serum protein 1.58
total mercury levels 1.58
total joint arthroplasty 1.58
tinnitus severity index 1.58
three-year immunization behavior 1.58
thorough quality assessment 1.58
thoracic aortic dissection 1.58
thirty-two work sites 1.58
thallium-201 exercise scintigraphy 1.58
term pregnant patients 1.58
temporary price increase 1.58
systolic blood pressure 1.58
systematic validity assessment 1.58
systematic health facility 1.58
symptom change patterns 1.58
sustained viral rebound 1.58
surgical weight loss 1.58
superficial wound hematomas 1.58
summary roc curve 1.58
such ecg changes 1.58
successful sexual functioning 1.58
substantial study variability 1.58
subsequent insulin studies 1.58
subsequent cesarean section 1.58
study quality mean 1.58
study group hospitals 1.58
students ' perceptions 1.58
strict literature search 1.58
stress management skills 1.58
stress management group 1.58
std risk reduction 1.58
statistical significance mean 1.58
state psychiatric hospital 1.58
standard intrauterine devices 1.58
standard drainage system 1.58
staff nurse perspective 1.58
staff model hmo 1.58
stable renal failure 1.58
squamous cell carcinoma 1.58
spontaneous vaginal delivery 1.58
spinal cord transection 1.58
spinal cord stimulation 1.58
specific skills training 1.58
specific preparation strategies 1.58
specific immune responses 1.58
specific estrogen receptors 1.58
specific analgesic effect 1.58
south australian children 1.58
somatic anxiety items 1.58
solid organ transplants 1.58
social marketing framework 1.58
social influences programmes 1.58
smoking prevention strategies 1.58
smoking intensity warrant 1.58
smoking cessation guideline 1.58
smokers ' reactions 1.58
smoke-free home policies 1.58
small physiological doses 1.58
small observational studies 1.58
small hepatocellular carcinoma 1.58
small carcinoid tumour 1.58
sleep continuity improvement 1.58
skin structure infections 1.58
skin hypersensitivity reactions 1.58
skin closure time 1.58
skills training participants 1.58
single serum sample 1.58
simvastatin-treated fh patients 1.58
simple implant treatment 1.58
simple anal dilatation 1.58
similar life transition 1.58
similar intervention programmes 1.58
showing dramatic decreases 1.58
shorter hospital stay 1.58
short-term regular beta 1.58
short-term cognitive functioning 1.58
short therapy interruptions 1.58
sexual risk behaviour 1.58
severe side effects 1.58
severe acute pancreatitis 1.58
session intervention group 1.58
serum plant sterols 1.58
serum half-life values 1.58
serum ferritin increments 1.58
serum cyclosporin levels 1.58
serum c-reactive protein 1.58
serum alt level 1.58
serious medical illness 1.58
serial impedance plethysmography 1.58
serial haemoglobin measurements 1.58
serial duplex sonography 1.58
sequential muscle ultrasound 1.58
separate double-blind trials 1.58
sensitive therapeutic classes 1.58
section infectious morbidity 1.58
section febrile morbidity 1.58
secondary end points 1.58
seat cushion system 1.58
seasonal affective disorder 1.58
scar volume changes 1.58
satisfactory clinical response 1.58
same pain course 1.58
safe delivery care 1.58
s personal qualities 1.58
rural health centers 1.58
routine vitamin supplementation 1.58
routine hemodynamic parameters 1.58
routine bedside evaluations 1.58
richards chs plate 1.58
rheumatoid pleural effusions 1.58
reverse transcriptase inhibitors 1.58
retrospective observational studies 1.58
retrospective cohort study 1.58
retail items contingent 1.58
resource utilisation parameters 1.58
residual wild-type virus 1.58
reproductive health services 1.58
representative household survey 1.58
repeated annual immunization 1.58
renal prostaglandin synthesis 1.58
renal function parameters 1.58
relevant age groups 1.58
regular maintenance dose 1.58
regional dna bank 1.58
regional area agency 1.58
refractory postoperative hemorrhage 1.58
refractory post-operative bleeding 1.58
reducing referral delay 1.58
reducing pain intensity 1.58
reducing emotional exhaustion 1.58
reducing blood cholesterol 1.58
reduced birth weight 1.58
recurrent variceal bleeding 1.58
recombinant human erythropoietin 1.58
recent onset psychosis 1.58
recent hiv infections 1.58
received standard heparin 1.58
rapid cycle improvement 1.58
rantes promoter region 1.58
randomized experimental design 1.58
randomized crossover study 1.58
randomised cross-over study 1.58
randomised comparative trial 1.58
random urine samples 1.58
random double-blind design 1.58
radioactive fibrinogen test 1.58
quasi-experimental control group 1.58
quantitative systematic review 1.58
quantitative real-time pcr 1.58
pulmonary wedge pressure 1.58
pulmonary vascular resistance 1.58
pulmonary function tests 1.58
published clinical trials 1.58
public relations campaign 1.58
ptsd symptom scale 1.58
psychosocial risk factors 1.58
psychiatric rating scales 1.58
prospective randomised manner 1.58
prophylactic low-dose heparin 1.58
property damage accidents 1.58
prolonged therapeutic hypothermia 1.58
prolonged artificial ventilation 1.58
professional task domains 1.58
private office setting 1.58
prior beta-blocker treatment 1.58
primary stroke prevention 1.58
primary patency rate 1.58
primary healthcare intervention 1.58
primary care treatment 1.58
primary care interventions 1.58
previous psychotherapy experience 1.58
previous affective disturbance 1.58
preoperative haemodynamic status 1.58
pregnancy intention status 1.58
pre-operative parenteral nutrition 1.58
practical support benefits 1.58
practical clinical interventions 1.58
ppm fluoride dentifrice 1.58
posttreatment self-help attendance 1.58
posttraumatic stress responses 1.58
posttest therapeutic gains 1.58
postpartum fecal incontinence 1.58
postoperative thrombotic complications 1.58
postoperative thromboembolic complications 1.58
postoperative pulmonary hypertension 1.58
postoperative pelvic drainage 1.58
postoperative mental impairment 1.58
postoperative antibiotic therapy 1.58
post-operative venous thromboembolism 1.58
positive instrumental changes 1.58
positive control toothpaste 1.58
positive bacterial cultures 1.58
popular education approaches 1.58
poor weight gain 1.58
poor finger function 1.58
pooled mortality rate 1.58
point rating scale 1.58
platelet mao activity 1.58
plasma viral load 1.58
plasma lipid profile 1.58
plasma hiv-1 rt 1.58
plasma calcium levels 1.58
placebo-controlled clinical trials 1.58
placebo baseline period 1.58
pilot prevention program 1.58
pilot intervention trial 1.58
physician work hours 1.58
physical therapy clinics 1.58
physical conditioning exercise 1.58
permanent farm workers 1.58
peripheral venous blood 1.58
percutaneous catheter fragmentation 1.58
pediatric cancer patients 1.58
patients unilateral dvt 1.58
patients ' viewpoint 1.58
patients ' quality 1.58
patients ' demographics 1.58
patients ' data 1.58
patients ' beliefs 1.58
patients ' anxiety 1.58
patients ' admission 1.58
patients ' acceptance 1.58
patient interactional style 1.58
patient death rates 1.58
patient care unit 1.58
pathogenic yeasts ws 1.58
parathyroid hormone values 1.58
pain threshold algometry 1.58
own lbw baby 1.58
overt emotional disturbance 1.58
overall survival curves 1.58
overall myocardial infarction 1.58
overall efficacy rates 1.58
overall cd4 cell 1.58
outpatient alcoholism treatment 1.58
outcome assessments points 1.58
oral propranolol regimen 1.58
oral health impact 1.58
oral cyclosporin a 1.58
oral cholera vaccines 1.58
optimal wound protection 1.58
operative mortality rate 1.58
operating room costs 1.58
operant learning theory 1.58
open surgical repair 1.58
open controlled study 1.58
only predictive factor 1.58
office building workers 1.58
oesophageal variceal hemorrhage 1.58
occult gastrointestinal bleeding 1.58
obstetric care services 1.58
nosocomial infection rates 1.58
north west england 1.58
north central region 1.58
normal marrow function 1.58
norepinephrine reuptake inhibitor 1.58
nonsteroidal antiinflammatory drugs 1.58
nonsteroidal anti-inflammatory agent 1.58
nonfatal cardiovascular events 1.58
non-pharmacological rehabilitation interventions 1.58
non-fatal pulmonary emboli 1.58
non denture wearers 1.58
non absorbable sutures 1.58
new therapeutic strategies 1.58
new skin cancers 1.58
new organizational forms 1.58
new generation antipsychotics 1.58
new combination therapy 1.58
neuroleptic treatment changes 1.58
neonatal adverse outcomes 1.58
negative syndrome scale 1.58
negative social consequences 1.58
national control programme 1.58
myeloma bone lesions 1.58
multistage dosing design 1.58
multiple response questionnaire 1.58
mouth syndrome symptoms 1.58
motor fluctuations occurrence 1.58
monthly cerebral mri 1.58
month study period 1.58
monoamine oxidase inhibitors 1.58
molecular pathologic investigation 1.58
modern hospital system 1.58
minor wound dehiscences 1.58
minor hemorrhagic complications 1.58
minimal staff involvement 1.58
minimal attention condition 1.58
min x m2 1.58
midwestern prevention project 1.58
midwestern community sample 1.58
mg i.v. furosemide 1.58
methadone maintenance treatment 1.58
methadone maintenance clients 1.58
metabolic clearance rates 1.58
mental health problems 1.58
mental health inventory 1.58
menopausal hormone regimens 1.58
megestrol acetate therapy 1.58
megestrol acetate dosage 1.58
medication education program 1.58
medication adherence intervention 1.58
median treatment time 1.58
median referral delay 1.58
median birth weight 1.58
mean weight gain 1.58
mean skin temperatures 1.58
mean post-operative drainage 1.58
mean percentage fall 1.58
mean implantation period 1.58
mean hospital stay 1.58
mean hip score 1.58
mean hemoglobin levels 1.58
mean ephedrine requirements 1.58
mean airway pressure 1.58
meal component requirements 1.58
maximum competitive advantage 1.58
maxillary central incisors 1.58
maternal cardiovascular consequences 1.58
mass media programming 1.58
markov regression modeling 1.58
many years yohimbine 1.58
malignant pleural effusions 1.58
male involvement scores 1.58
major surgical operations 1.58
major postoperative bleeding 1.58
major post-operative bleeding 1.58
major metropolitan sites 1.58
major bleeding events 1.58
lowest postsurgical weight 1.58
lower plasma concentrations 1.58
lower limb cellulitis 1.58
lower extremity dvt 1.58
lower default rate 1.58
lower alcohol use 1.58
low-grade intraventricular hemorrhage 1.58
low-dose inhaled corticosteroids 1.58
low-dose fish oil 1.58
low-dose daily chemotherapy 1.58
low risk women 1.58
low mortality rate 1.58
low methodological rigour 1.58
low fracture risk 1.58
low fluoride group 1.58
low dose irradiation 1.58
low dose aspirin 1.58
low cardiac output 1.58
longitudinal representative sample 1.58
long-term treatment effects 1.58
long-term mechanical ventilation 1.58
long-term anticoagulant treatment 1.58
long-term abstinence reinforcement 1.58
long term efficacy 1.58
logistic regression model 1.58
localised prostate cancer 1.58
local wound complications 1.58
local vaginal treatment 1.58
local classroom teachers 1.58
live kidney donation 1.58
little research attention 1.58
little reproducible evidence 1.58
little long-term effect 1.58
little clinical relevance 1.58
lipoprotein cholesterol reduction 1.58
limited quality assessment 1.58
limited literature search 1.58
limited english proficiency 1.58
light general anesthesia 1.58
life threatening disorder 1.58
legislative changes study 1.58
left ventricular failure 1.58
left ventricular dysfunction 1.58
left hippocampal volume 1.58
ldl cholesterol concentrations 1.58
late deep infections 1.58
large sample population 1.58
large randomised trial 1.58
large government hospital 1.58
large effect size 1.58
large central emboli 1.58
japanese dengue patients 1.58
item hamilton depression 1.58
isotope leg scanning 1.58
ischemic heart disease 1.58
investigators ' group 1.58
invasive hip replacement 1.58
intrinsic eyelid inflammation 1.58
intramuscular interferon-beta ia 1.58
intolerable adverse events 1.58
interpreting ethnic differentials 1.58
intermittent i.v. boluses 1.58
intercollegiate guidelines network 1.58
interactive computer program 1.58
intensive statin treatment 1.58
intensive program services 1.58
intensive nutritional support 1.58
intensive neonatal care 1.58
insulin insensitive type 1.58
initial treatment failure 1.58
initial patient characteristics 1.58
inhaled bronchodilator use 1.58
infrequent obstetric therapy 1.58
informed consent group 1.58
informal delivery setting 1.58
influenza virus vaccines 1.58
infectious diseases consortium 1.58
infant mortality rate 1.58
inexpensive technical approaches 1.58
indoor air legislation 1.58
individual study details 1.58
indigent pregnant women 1.58
independent predictive factors 1.58
increases energy expenditure 1.58
improving ultrasonic resolution 1.58
improved long-term course 1.58
immobilized medical patients 1.58
immature preterm infants 1.58
icd generator reliability 1.58
human recombinant protein 1.58
hours ' duration 1.58
hospital technical efficiency 1.58
home intervention services 1.58
home care programme 1.58
hiv-specific cd4 subpopulation 1.58
hiv status disclosure 1.58
histological oesophagitis score 1.58
hip rating outcomes 1.58
hip outcome instrument 1.58
high-risk elderly patients 1.58
high tibial osteotomy 1.58
high tb prevalence 1.58
high survival rate 1.58
high school years 1.58
high quality analgesia 1.58
high pulmonary flow 1.58
high probability scan 1.58
high drop-out rate 1.58
high dependency unit 1.58
high blood pressure 1.58
herbal medicinal products 1.58
hepatocellular carcinoma tissue 1.58
hemagglutination inhibition assays 1.58
helper t-cell responses 1.58
helicobacter pylori detection 1.58
heaviest smoking levels 1.58
healthy young adults 1.58
healthcare ' s 1.58
health risk categories 1.58
health promotion efforts 1.58
health promotion activities 1.58
health policy components 1.58
health maintenance procedures 1.58
health insurance market 1.58
health consequences program 1.58
health care settings 1.58
health care facility 1.58
health care facilities 1.58
hdl cholesterol concentrations 1.58
hbv-dna positive cirrhosis 1.58
harlem aids project 1.58
haloperidol treated patients 1.58
guiding catheter ablation 1.58
group mean maximum 1.58
group discussion intervention 1.58
gram-positive bacterial infections 1.58
gram-negative bacteremic patients 1.58
gram-negative bacillary infections 1.58
genetic testing market 1.58
generalized leontief function 1.58
generalised anxiety disorder 1.58
general surgical wounds 1.58
general surgery clinic 1.58
general poor quality 1.58
general nurses register 1.58
general abdominal surgery 1.58
functional symptomatic pattern 1.58
fresh tibial fractures 1.58
frequent unwanted symptom 1.58
frequent risk factor 1.58
former placebo group 1.58
formal validity assessment 1.58
follow-up response rates 1.58
folic acid benefits 1.58
fluoride dose-response evaluation 1.58
first treatment period 1.58
first such program 1.58
first posttest period 1.58
first postoperative year 1.58
first follow-up visit 1.58
first drinking episode 1.58
first cranial sonogram 1.58
fifty-three asthmatic patients 1.58
fifth postoperative day 1.58
femoral neck fracture 1.58
female psychiatric outpatients 1.58
female ibs patients 1.58
female education level 1.58
feasible research designs 1.58
family treatment group 1.58
extensive online patient 1.58
expert knowledge base 1.58
experimental field study 1.58
existing randomized trials 1.58
executive control processes 1.58
ethnic minority groups 1.58
erythrocyte glutathione concentration 1.58
equivalent consent rates 1.58
english language literature 1.58
end-stage renal failure 1.58
end point reduction 1.58
emergency obstetric care 1.58
emergency medical service 1.58
emergency department population 1.58
elevated ion concentrations 1.58
elective colorectal surgery 1.58
effective therapeutic regimen 1.58
effective palliative treatment 1.58
effective oral analgesic 1.58
effective evidence-based care 1.58
effective distribution strategies 1.58
effective clinical intervention 1.58
effective behavioral interventions 1.58
educational attainment scores 1.58
early therapeutic interventions 1.58
early systemic complications 1.58
early surgical treatment 1.58
early radiation therapy 1.58
early ovarian cancer 1.58
early graft failure 1.58
early clot lysis 1.58
early clinical experience 1.58
dsm-iii-r schizoaffective subjects 1.58
dsm-iii-r anorexia nervosa 1.58
dry powder inhalers 1.58
drug order notations 1.58
double-blind study group 1.58
double-blind randomized fashion 1.58
double-blind intravenous treatment 1.58
double-blind crossover comparison 1.58
disseminated quality indicators 1.58
disease activity score 1.58
different treatment outcome 1.58
different histologic types 1.58
different clinical scenarios 1.58
diagnostic test research 1.58
diabetes education programs 1.58
detecting pulmonary embolism 1.58
detecting pelvic fractures 1.58
defective government policies 1.58
deep-vein thrombosis prevention 1.58
deep wound hematomas 1.58
deep intravenous sedation 1.58
decreasing tissue hardness 1.58
day cyclosporin a 1.58
data envelopment analysis 1.58
data collection method 1.58
cyclooxygenase-2 selective inhibitor 1.58
current follow-up period 1.58
current diagnostic criteria 1.58
cumulative one-year probability 1.58
ctc toxicity criteria 1.58
cross-sectional questionnaire study 1.58
critical research skills 1.58
critical organ bleeding 1.58
credible role models 1.58
creatinine ratio measurements 1.58
cox regression models 1.58
cost comparison analysis 1.58
coronary artery stents 1.58
coronary artery angiography 1.58
conventional psychological approach 1.58
conventional low-dose heparin 1.58
conventional hospital care 1.58
conventional antibiotic drops 1.58
controlled observational studies 1.58
control work sites 1.58
contracting cardiovascular diseases 1.58
continuous wound closure 1.58
continuous intravenous heparin 1.58
consultant pathologist costs 1.58
consistent pharmacokinetic strategy 1.58
consistent abstinence rates 1.58
consequent health risks 1.58
consent rate b 1.58
consent rate a 1.58
concurrent mood symptoms 1.58
concurrent individual therapy 1.58
concomitant sleep problems 1.58
concomitant sleep disturbances 1.58
computer-generated randomization model 1.58
complication odds ratio 1.58
complex clinical trials 1.58
complete group treatment 1.58
complete filling defects 1.58
complete ductal closure 1.58
comparative clinical trial 1.58
comparable art restorations 1.58
community-based service use 1.58
committees select activities 1.58
columbia general hospital 1.58
collagen type-i carrier 1.58
cognitive test scores 1.58
close family members 1.58
clomiphene citrate treatment 1.58
clock drawing test 1.58
clinician time utilization 1.58
clinical pregnancy rates 1.58
clients quit smoking 1.58
chronic liver disease 1.58
chronic hiv-infected patients 1.58
chronic health evaluation 1.58
childrens ' mealtimes 1.58
child assessment centers 1.58
changing workplace attitudes 1.58
cesarean section case 1.58
cerebrospinal fluid pressure 1.58
cerebral palsy patients 1.58
central memory subsets 1.58
cd27 cd45ra phenotype 1.58
caudal extradural injection 1.58
caries id rates 1.58
care manager contacts 1.58
capitation physician referrals 1.58
bypass graft occlusions 1.58
bone cortical thickness 1.58
body weight gain 1.58
body ct scan 1.58
blood urea nitrogen 1.58
blood salvage device 1.58
blood prolactin levels 1.58
blind group comparison 1.58
biophysical profile incorporating 1.58
bilateral diastolic notch 1.58
beth israel hospital 1.58
baseline motor function 1.58
baseline cross-sectional study 1.58
baseline creatinine clearance 1.58
average peak concentrations 1.58
available survey data 1.58
automated telephone message 1.58
australian capital territory 1.58
atherosclerosis plaque formation 1.58
assisted reproductive technology 1.58
arthroscopic knee surgery 1.58
arterial blood gases 1.58
appropriate health care 1.58
appropriate control conditions 1.58
aortic valve replacement 1.58
antidepressant drug treatment 1.58
antidepressant drug therapy 1.58
antenatal care visit 1.58
animal model data 1.58
ancillary hiv services 1.58
america ' s 1.58
amenorrhoeic premenopausal women 1.58
ambulatory ms patients 1.58
alternative community models 1.58
allogeneic blood transfusions 1.58
alcohol use measures 1.58
alcohol prevention programmes 1.58
alcohol prevention activities 1.58
alcohol educational program 1.58
alcohol abuse prevention 1.58
aids prevention strategies 1.58
age-related limited durability 1.58
adverse event profile 1.58
advanced stomach cancer 1.58
advanced rectal cancer 1.58
advanced practice nurse 1.58
advanced lung cancer 1.58
advanced breast carcinomas 1.58
adult-onset rheumatoid arthritis 1.58
adult cancer patients 1.58
adult ambulatory patients 1.58
adrenergic agonists treatment 1.58
adolescent alcohol overindulgence 1.58
adjacent tooth surfaces 1.58
adequate thrombosis prophylaxis 1.58
adequate control groups 1.58
additive analgesic efficacy 1.58
acute stroke study 1.58
acute phase parameters 1.58
acute pain services 1.58
acute myeloid leukaemia 1.58
acute major depression 1.58
acute drug testing 1.58
acute bronchial asthma 1.58
acute abdominal operations 1.58
actual drug use 1.58
actual consent process 1.58
active mri lesions 1.58
acid adjunctive therapy 1.58
accessible exercise intervention 1.58
acceptable routine method 1.58
abrupt withdrawal group 1.58
abnormal noninvasive testing 1.58
a systematic review 1.58
a > g 1.58
' t rule 1.58
' s lymphoma 1.58